AsimAminMD

PubMed

• Nivolumab monotherapy or combination with ipilimumab with or without cobimetinib in previously treated patients with pancreatic adenocarcinoma (CheckMate 032).
  Margaret Callahan, Asim Amin, Frederic J Kaye, Michael A Morse, Matthew H Taylor, Katriina J Peltola, Padmanee Sharma, Eileen M O'Reilly, Stephanie Meadows Shropshire,...> ;Journal for Immunotherapy of Cancer. 2024 Feb 5
• Distinct Predictive Immunogenomic Profiles of Response to Immune Checkpoint Inhibitors and IL2: A Real-world Evidence Study of Patients with Advanced Renal Cancer.
  Joel R Eisner, Kirk D Beebe, Gregory M Mayhew, Yoichiro Shibata, Yuelong Guo, Carol Farhangfar, Farhang Farhangfar, Joshua M Uronis, Jill Mooney, Michael V Milburn, Da...> ;Cancer Research Communications. 2022 Aug 1
• 14 citations
  Venous thromboembolism incidence and risk factors in non-small cell lung cancer patients receiving first-line systemic therapy.
  Hailey Hill, Myra M. Robinson, Lauren Lu, Daniel Slaughter, Asim Amin, Kathryn Finch Mileham, Jai N. Patel> ;Thrombosis Research. 2021 Oct 26
• 11 citations
  Long-term progression-free survival of patients with metastatic melanoma or renal cell carcinoma following high-dose interleukin-2.
  Joseph I. Clark, Brendan Curti, Elizabeth J. Davis, Howard L. Kaufman, Asim Amin, Ajjai Alva, Theodore F. Logan, Ralph J. Hauke, Gerald P Miletello, Ulka N. Vaishampay...> ;Journal of Investigative Medicine. 2021 Feb 4
• 150 citations
  Survival outcomes and independent response assessment with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma: 42-month follow-u...
  Robert J. Motzer, Bernard Escudier, David F. McDermott, Osvaldo Arén Frontera, Bohuslav Melichar, Thomas Powles, Frede Donskov, Elizabeth R. Plimack, Philippe Barthélé...> ;Journal for Immunotherapy of Cancer. 2020 Jul 1
• 122 citations
  Neoadjuvant Nivolumab for Patients With Resectable Merkel Cell Carcinoma in the CheckMate 358 Trial
  Suzanne L. Topalian, Shailender Bhatia, Asim Amin, Ragini R. Kudchadkar, William H. Sharfman, Céleste Lebbé, Jean Pierre Delord, Lara Dunn, Michi M. Shinohara, Rima M....> ;Journal of Clinical Oncology. 2020 Apr 23
• 163 citations
  Nivolumab Monotherapy and Nivolumab Plus Ipilimumab in Recurrent Small Cell Lung Cancer: Results From the CheckMate 032 Randomized Cohort
  Neal Ready, Patrick A. Ott, Matthew D. Hellmann, Jon Zugazagoitia, Christine L. Hann, Filippo de Braud, Scott J. Antonia, Paolo A. Ascierto, Victor Moreno, Akin Atmaca...> ;Journal of Thoracic Oncology. 2020 Mar 1
• 38 citations
  Intracranial antitumor activity with encorafenib plus binimetinib in patients with melanoma brain metastases: A case series.
  Kourtney Holbrook, Jose Lutzky, Michael A. Davies, Jessica Michaud Davis, Isabella C. Glitza, Rodabe N. Amaria, Adi Diab, Sapna Pradyuman Patel, Asim Amin, Hussein Abd...> ;Cancer. 2020 Feb 1
• 494 citations
  Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomis...
  Robert J. Motzer, Brian I. Rini, David F. McDermott, Osvaldo Arén Frontera, Hans J. Hammers, Michael A. Carducci, Pamela Salman, Bernard Escudier, Benoit Beuselinck, A...> ;The Lancet. Oncology. 2019 Oct 1
• 4 citations
  Correction to: Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: The CheckMate 016 study (Jou...
  Asim Amin, Elizabeth R. Plimack, Marc S. Ernstoff, Lionel D. Lewis, Todd M. Bauer, David F. McDermott, Michael A. Carducci, Christian Kollmannsberger, Brian I. Rini, D...> ;Journal for Immunotherapy of Cancer. 2019 Mar 14
• 13 citations
  Flexible Sigmoidoscopy Rather than Colonoscopy Is Adequate for the Diagnosis of Ipilimumab-Associated Colitis.
  J Daniel Herlihy, Stephen Beasley, Andrew Simmelink, Vinaya Maddukuri, Asim Amin, Michal Kamionek, Carl Jacobs, Krista Bossi, Martin Scobey> ;Southern Medical Journal. 2019 Mar 1
• 26 citations
  The evolving landscape of immunotherapy-based combinations for frontline treatment of advanced renal cell carcinoma
  Asim Amin, Hans J. Hammers> ;Frontiers in Immunology. 2019 Jan 10
• 24 citations
  Spectrum and prevalence of BRCA1/2 germline mutations in Pakistani breast cancer patients: results from a large comprehensive study.
  Muhammad Usman Rashid, Noor Muhammad, Humaira Naeemi, Faiz Ali Khan, Mariam Hassan, Saima Faisal, Sidra Gull, Asim Amin, Asif Loya, Ute Hamann> ;Hereditary Cancer in Clinical Practice. 2019 Sep 11
• 49 citations
  Immune checkpoint inhibitors in MITF family translocation renal cell carcinomas and genetic correlates of exceptional responders
  Alice Boilève, Maria I. Carlo, Philippe Barthélémy, Stéphane Oudard, Delphine Borchiellini, Martin H. Voss, Saby George, Christine Chevreau, Judith Landman-Parker, M-D...> ;Journal for Immunotherapy of Cancer. 2018 Dec 27
• 46 citations
  Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study.
  Asim Amin, Elizabeth R Plimack, Marc S Ernstoff, Lionel D Lewis, Todd M Bauer, David F McDermott, Michael Carducci, Christian Kollmannsberger, Brian I Rini, Daniel Y C...> ;Journal for Immunotherapy of Cancer. 2018 Oct 22
• 10 citations
  First-line vascular endothelial growth factor targeted therapy in renal cell carcinoma: priming the tumor microenvironment for immunotherapy.
  Nizar M. Tannir, Hans J. Hammers, Asim Amin> ;Current Medical Research and Opinion. 2018 Feb 1
• 189 citations
  SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter Study
  Antoni Ribas, Theresa Medina, Shivaani Kummar, Asim Amin, Anusha Kalbasi, Joseph J. Drabick, Minal A. Barve, Gregory A. Daniels, Deborah J. Wong, Emmett V. Schmidt, Al...> ;Cancer Discovery. 2018 Jan 1
• 306 citations
  Safety and Efficacy of Nivolumab in Combination With Ipilimumab in Metastatic Renal Cell Carcinoma: The CheckMate 016 Study
  Hans J. Hammers, Elizabeth R. Plimack, Jeffrey R. Infante, Brian I. Rini, David F. McDermott, Lionel D. Lewis, Martin H. Voss, Padmanee Sharma, Sumanta K. Pal, Albirun...> ;Journal of Clinical Oncology. 2017 Jul 5
• 25 citations
  Impact of Sequencing Targeted Therapies With High-dose Interleukin-2 Immunotherapy: An Analysis of Outcome and Survival of Patients With Metastatic Renal Cell Carcinom...
  Joseph I. Clark, Michael K.K. Wong, Howard L. Kaufman, Gregory A. Daniels, Michael A. Morse, David F. McDermott, Sanjiv S. Agarwala, Lionel D. Lewis, John H. Stewart, ...> ;Clinical Genitourinary Cancer. 2017 Feb 1
• 11 citations
  Contribution of BRCA1 large genomic rearrangements to early-onset and familial breast/ovarian cancer in Pakistan.
  Muhammad Usman Rashid, Noor Muhammad, Asim Amin, Asif Loya, Ute Hamann> ;Breast Cancer Research and Treatment. 2017 Jan 1
• 67 citations
  Contemporary experience with high-dose interleukin-2 therapy and impact on survival in patients with metastatic melanoma and metastatic renal cell carcinoma
  Ajjai Alva, Gregory A. Daniels, Michael K.K. Wong, Howard L. Kaufman, Michael A. Morse, David F. McDermott, Joseph I. Clark, Sanjiv S. Agarwala, Gerald P Miletello, Th...> ;Cancer Immunology, Immunotherapy. 2016 Oct 6
• 21 citations
  High prevalence and predominance of BRCA1 germline mutations in Pakistani triple-negative breast cancer patients.
  Muhammad Usman Rashid, Noor Muhammad, Seerat Bajwa, Saima Faisal, Muhammad Tahseen, Justo Lorenzo Bermejo, Asim Amin, Asif Loya, Ute Hamann> ;BMC Cancer. 2016 Aug 23
• 47 citations
  Phase II study of vemurafenib followed by ipilimumab in patients with previously untreated BRAF-mutated metastatic melanoma
  Asim Amin, David H. Lawson, April K.S. Salama, Henry B. Koon, Troy H. Guthrie, Sajeve S. Thomas, Steven J. O'Day, Montaser Shaheen, Bin Zhang, Stephen Francis, F. Step...> ;Journal for Immunotherapy of Cancer. 2016 Aug 16
• 875 citations
  Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial
  Scott J. Antonia, Jose A. Lopez-Martin, Johanna C. Bendell, Patrick A. Ott, Matthew H. Taylor, Joseph Paul Eder, Dirk Jäger, M. Catherine Pietanza, Dung T. Le, Filippo...> ;The Lancet. Oncology. 2016 Jul 1
• 6 citations
  Skin manifestations associated with kidney cancer
  Asim Amin, Earle F. Burgess> ;Seminars in Oncology. 2016 Jun 1
• Join now to see all

Lectures

• Phase 1b/2, open label, multicenter, study of the combination of SD-101 and pembrolizumab in patients with advanced/metastatic melanoma resistant to anti-PD-1/PD-L1 th... 
  ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019